Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anselm Jorda

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Expert Review of Clinical Pharmacology|April 14, 2021
Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogensAnselm Jorda, Markus Zeitlinger
Lancet (London, England)|May 10, 2026
Zoliflodacin: non-inferior, but not equivalent?Anselm Jorda, Markus Zeitlinger
Critical Care Medicine|November 20, 2025
The authors replyAnselm Jorda, Georg Gelbenegger
Critical Care Medicine|October 7, 2025
The authors replyGeorg Gelbenegger, Anselm Jorda
The Lancet. Respiratory Medicine|September 3, 2022
Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?Anselm Jorda, Markus Zeitlinger
Clinical Pharmacokinetics|May 2, 2020
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A ReviewAnselm Jorda, Markus Zeitlinger
Journal of Internal Medicine|August 4, 2025
Authors' reply: Systolic blood pressure targets below 120 mmHg are associated with reduced mortality: A meta-analysisFelix Bergmann, Markus Zeitlinger, Anselm Jorda
The New England Journal of Medicine|June 21, 2023
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Felix Bergmann, Anselm Jorda, Markus Zeitlinger
International Journal of Antimicrobial Agents|February 25, 2026
In reply to the Letter to Editor regarding 'Pharmacokinetics of Ampicillin, Sulbactam, and Combined Ampicillin/Sulbactam in Subcutis, Muscle, and Plasma: A Microdialysis Trial in Healthy Volunteers'Anselm Jorda, Markus Zeitlinger, Valentin Al Jalali
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2024
Revisiting the Evidence: Corticosteroid Efficacy in Patients With Moderate and Severe Community-Acquired PneumoniaFelix Bergmann, Christine Radtke, Markus Zeitlinger, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Expert Review of Clinical Pharmacology|April 14, 2021
Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogensAnselm Jorda, Markus Zeitlinger
Lancet (London, England)|May 10, 2026
Zoliflodacin: non-inferior, but not equivalent?Anselm Jorda, Markus Zeitlinger
Critical Care Medicine|November 20, 2025
The authors replyAnselm Jorda, Georg Gelbenegger
Critical Care Medicine|October 7, 2025
The authors replyGeorg Gelbenegger, Anselm Jorda
The Lancet. Respiratory Medicine|September 3, 2022
Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?Anselm Jorda, Markus Zeitlinger
Clinical Pharmacokinetics|May 2, 2020
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A ReviewAnselm Jorda, Markus Zeitlinger
Journal of Internal Medicine|August 4, 2025
Authors' reply: Systolic blood pressure targets below 120 mmHg are associated with reduced mortality: A meta-analysisFelix Bergmann, Markus Zeitlinger, Anselm Jorda
The New England Journal of Medicine|June 21, 2023
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Felix Bergmann, Anselm Jorda, Markus Zeitlinger
International Journal of Antimicrobial Agents|February 25, 2026
In reply to the Letter to Editor regarding 'Pharmacokinetics of Ampicillin, Sulbactam, and Combined Ampicillin/Sulbactam in Subcutis, Muscle, and Plasma: A Microdialysis Trial in Healthy Volunteers'Anselm Jorda, Markus Zeitlinger, Valentin Al Jalali
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2024
Revisiting the Evidence: Corticosteroid Efficacy in Patients With Moderate and Severe Community-Acquired PneumoniaFelix Bergmann, Christine Radtke, Markus Zeitlinger, et al.
Pageof 7